Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+99.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
31.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 565.22% |
| Q2 2025 | -4.55% |
| Q1 2025 | 47.62% |
| Q4 2024 | -35.48% |
| Q3 2024 | -14.81% |
| Q2 2024 | 41.30% |
| Q1 2024 | 11.54% |
| Q4 2023 | 1.89% |
| Q3 2023 | -8.16% |
| Q2 2023 | 19.67% |
| Q1 2023 | -45.24% |
| Q4 2022 | 8.70% |
| Q3 2022 | -24.32% |
| Q2 2022 | -15.62% |
| Q1 2022 | -135.56% |
| Q4 2021 | -87.64% |
| Q3 2021 | 351.03% |
| Q2 2021 | 58.98% |
| Q1 2021 | -177.25% |
| Q4 2020 | 33.59% |
| Q3 2020 | 17.95% |
| Q2 2020 | -161.82% |
| Q1 2020 | 223.90% |
| Q4 2019 | -135.91% |
| Q3 2019 | 80.76% |
| Q2 2019 | -705.99% |
| Q1 2019 | 4.02% |
| Q4 2018 | 52.20% |
| Q3 2018 | -14.47% |
| Q2 2018 | -43.24% |
| Q1 2018 | 39.51% |
| Q4 2017 | 50.27% |
| Q3 2017 | -24.45% |
| Q2 2017 | -20.28% |
| Q1 2017 | -69.42% |
| Q4 2016 | -115.30% |
| Q3 2016 | 391.27% |
| Q2 2016 | 17.96% |
| Q1 2016 | 27.64% |
| Q4 2015 | -5.36% |